Bill Ackman is putting a modern-day spin on a centuries-old financial innovation with the special purpose acquisition company he plans to take public.
Keep Reading →
July 8 - Hedge Funds, Insider Trading
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy...
Keep Reading →
July 8 - Hedge Funds, News
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Keep Reading →
June 4 - Hedge Funds, News
Coronavirus is probably the #1 concern in investors' minds right now. It should be.
Keep Reading →
May 4 - Hedge Funds, News
Coronavirus is probably the #1 concern in investors’ minds right now. It should be.
Keep Reading →
March 11 - Hedge Funds, News
We are still in an overall bull market and many stocks that smart money investors were piling into surged in 2019.
Keep Reading →
December 26 - Hedge Funds, News
Last year's fourth quarter was a rough one for investors and many hedge funds, which were naturally unable to overcome the big dip in the broad market, as the S&P 500 fell by ...
Keep Reading →
December 3 - Hedge Funds, News
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 750 active prominent money ...
Keep Reading →
October 15 - Hedge Funds, News
Is Incyte Corporation (NASDAQ:INCY) a good stock to buy right now? We at Insider Monkey like to examine what billionaires and hedge funds think of a company before doing days ...
Keep Reading →
June 13 - Hedge Funds, News
Many investors, including Paul Tudor Jones or Stan Druckenmiller, have been saying before the Q4 market crash that the stock market is overvalued due to a low interest rate environment...
Keep Reading →
April 1 - Hedge Funds, News
Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals.
Keep Reading →
December 10 - Hedge Funds, News
Tesla Motors Inc (NASDAQ:TSLA) CEO Elon Musk has made amends with investors of his company after a poorly handled earnings call last week sent shares of the electric automaker...
Keep Reading →
May 8 - Insider Trading, News, Tech
"Stocks rose on Wall Street on Thursday, capping a wave of declines in major world equity markets triggered by uncertainty over U.S.
Keep Reading →
May 18 - Commodities, Futures/Forex, Gold, Market Movers, News, Tech
"U.S. equities rose on Monday as a weekend filled with geopolitical worries ended more calmly than investors expected, while bank stocks charged ahead.
Keep Reading →
April 17 - Commodities, Gold, Market Movers, News, Tech
Traders are watching Incyte Corporation (NASDAQ:INCY) after Geoff Meacham of Barclays hiked his price target on the biotech to $185 per share from $135.
Keep Reading →
April 7 - News
If, back in 2013, you invested in at least one of the 11 fastest growing S&P 500 companies in America, chances are that you are one happy (and possibly much wealthier) shareholder...
Keep Reading →
April 4 - Lists, News
The market has been volatile due to elections and the potential of another Federal Reserve rate increase.
Keep Reading →
November 28 - Hedge Funds, News
Bringing something new to the table is something that seems to be difficult these days, considering that many things have already been done, have already been invented, and have...
Keep Reading →
October 26 - Hedge Funds, Lists, News
While several hedge funds have suffered enormous losses this year due to their investments in biotech stocks, the performance of the leading biotech-focused hedge fund Baker Bros...
Keep Reading →
May 7 - Hedge Fund Analysis, Hedge Funds, News
It is generally believed that individuals seeking to become millionaires (and who isn't?) need to think and act like millionaires.
Keep Reading →
March 18 - Hedge Funds, News
Baker Bros. Advisors is a New York City-based fund launched in 2000 by Julian and Felix Baker.
Keep Reading →
February 25 - Hedge Funds, News
Baker Bros. Advisors is one of the most famous healthcare-focused equity hedge funds in the world today.
Keep Reading →
December 9 - Hedge Fund Analysis, Hedge Funds, News
Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end...
Keep Reading →
December 1 - Hedge Funds, News
As the markets are mixed on Tuesday, fueled by a surge in oil prices, among the crowd of stocks moving in different directions, shares of Encana Corporation (USA) (NYSE:ECA), ...
Keep Reading →
October 6 - Market Movers, News
Eli Lilly and Co (NYSE:LLY) and Incyte Corporation (NASDAQ:INCY) are experiencing volatility at Tuesday’s open, initially moving in different directions before both started ...
Keep Reading →
September 29 - Market Movers, News
With the rapid pace of M&A happening in the biotechnology sector, Julian Baker and Felix Baker's Baker Bros. Advisors is making a habit of hitting home runs in 2015.
Keep Reading →
July 10 - Hedge Funds, News
Julian Baker and Felix Baker's Baker Bros. Advisors’ top pick from the end of 2014 has paid off for the fund in a big way in 2015.
Keep Reading →
March 5 - Hedge Funds, News
Julian and Felix Baker's Baker Bros. Advisors has decreased its stake in MEI Pharma Inc (NASDAQ:MEIP) to 746,521 shares, from 1,130,317 shares revealed as held earlier.
Keep Reading →
January 2 - Hedge Funds, News
Julian and Felix Baker and their hedge fund, Baker Bros.
Keep Reading →
November 15 - Hedge Funds, News
At the moment, there are many indicators investors can use to analyze stocks. Some of the most under-the-radar are hedge fund and insider trading activity.
Keep Reading →
September 12 - News
Analyst downgrades are a dime a dozen. They often move stocks, but few are what I would consider good calls.
Keep Reading →
September 11 - News
At the moment, there are a multitude of metrics shareholders can use to monitor stocks. A pair of the most useful are hedge fund and insider trading sentiment.
Keep Reading →
September 10 - News
Earlier this month, I wrote an article explaining that I liked Incyte Corporation (NASDAQ:INCY) on the basis of the blockbuster potential of its only approved drug, Jakafi...
Keep Reading →
September 6 - News
As an investor in the health care sector, it can sometimes feel like everything -- and everyone -- is out to get you.
Keep Reading →
August 30 - News
In the 21st century investor’s toolkit, there are many gauges shareholders can use to track their holdings.
Keep Reading →
August 30 - News
In the financial world, there are many methods shareholders can use to track stocks. A couple of the most innovative are hedge fund and insider trading activity.
Keep Reading →
August 27 - News
In today’s marketplace, there are a multitude of gauges market participants can use to analyze their holdings.
Keep Reading →
August 27 - News
Incyte Corporation (NASDAQ:INCY) takes the top spot on our humongous health-care stocks list.
Keep Reading →
August 26 - News
With the SPDR S&P Biotech Index up 37% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Keep Reading →
August 25 - News
In today’s marketplace, there are a multitude of methods shareholders can use to monitor the equity markets.
Keep Reading →
August 25 - News
There's been plenty of buzz lately about the continuing saga of the possible buyout of Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) by Amgen, Inc. (NASDAQ:AMGN).
Keep Reading →
August 23 - News
For a subgroup of the patients, the hazard ratio for overall survival in late-stage pancreatic cancer patients taking Incyte Corporation (NASDAQ:INCY)'s Jakafi and Roche's Xeloda...
Keep Reading →
August 23 - News
While I do think it's possible that MannKind Corporation (NASDAQ:MNKD)'s inhaled insulin device, Afrezza, will be approved by the Food and Drug Administration, I do have serious...
Keep Reading →
August 22 - News
One of the hottest stocks on the market Wednesday was Incyte Corporation (NASDAQ:INCY), a pharmaceutical company specializing in the development of JAK inhibitors.
Keep Reading →
August 22 - News
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis...
Keep Reading →
August 21 - News
Incyte Corporation (NASDAQ:INCY) rose the most in more than five years after the company said its leukemia drug helped a subgroup of patients with advanced pancreatic cancer ...
Keep Reading →
August 21 - News
Incyte Corporation (NASDAQ:INCY) today announced positive results from a phase 2 study of its drug Jakafi in treating refractory metastatic pancreatic cancer.
Keep Reading →
August 21 - News
The buyout drama surrounding cancer drug maker Onyx Pharmaceuticals, Inc.
Keep Reading →
August 16 - News
Budding biotech company Incyte Corporation (NASDAQ:INCY), which specializes in developing novel JAK inhibitors, released solid second-quarter earnings on Wednesday.
Keep Reading →
August 1 - News
